IS5029A - Aðferð fyrir setin pýridín - Google Patents

Aðferð fyrir setin pýridín

Info

Publication number: IS5029A
Authority: IS; Iceland
Prior art keywords: substituted pyridine; pyridine; substituted
Prior art date: 1996-11-14

Application number

IS5029A

Other languages

English (en)

Inventor

Michael Devries Keith

Lee Dow Robert

Wayne Wright Stephen

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-14

Filing date

1999-04-16

Publication date

1999-04-16

1999-04-16 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

1999-04-16 Publication of IS5029A publication Critical patent/IS5029A/is

Links

UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1
JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 1
150000003222 pyridines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pyridine Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)

IS5029A 1996-11-14 1999-04-16 Aðferð fyrir setin pýridín IS5029A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3088096P	1996-11-14	1996-11-14
PCT/IB1997/001367 WO1998021184A1 (en)	1996-11-14	1997-11-03	Process for substituted pyridines

Publications (1)

Publication Number	Publication Date
IS5029A true IS5029A (is)	1999-04-16

Family

ID=21856496

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5029A IS5029A (is)	1996-11-14	1999-04-16	Aðferð fyrir setin pýridín

Country Status (32)

Country	Link
US (1)	US6291489B1 (is)
EP (1)	EP0938476B1 (is)
JP (1)	JP3510635B2 (is)
KR (1)	KR20000053314A (is)
CN (1)	CN1237160A (is)
AP (1)	AP805A (is)
AR (1)	AR010584A1 (is)
AT (1)	ATE319687T1 (is)
AU (1)	AU4634697A (is)
BG (1)	BG103393A (is)
BR (1)	BR9712951A (is)
CA (1)	CA2270386C (is)
CO (1)	CO4930261A1 (is)
DE (1)	DE69735433D1 (is)
EA (1)	EA199900375A1 (is)
GT (1)	GT199700118A (is)
HR (1)	HRP970612A2 (is)
ID (1)	ID18898A (is)
IL (1)	IL129688A0 (is)
IS (1)	IS5029A (is)
MA (1)	MA24401A1 (is)
MY (1)	MY132507A (is)
NO (1)	NO992296D0 (is)
OA (1)	OA11044A (is)
PA (1)	PA8441401A1 (is)
PE (1)	PE10299A1 (is)
TN (1)	TNSN97172A1 (is)
TR (1)	TR199901063T2 (is)
UY (1)	UY24774A1 (is)
WO (1)	WO1998021184A1 (is)
YU (1)	YU22099A (is)
ZA (1)	ZA9710186B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20010042518A (ko) *	1998-04-08	2001-05-25	한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터	신규 제초제
US6090942A (en) *	1998-10-15	2000-07-18	Pfizer Inc.	Process and intermediates for a β3 -adrenergic receptor agonist
EP1153919A4 (en) *	1999-02-16	2002-10-02	Kaneka Corp	SUBSTITUTED ACETYLPYRIDINE DERIVATIVES AND PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR OPTICALLY ACTIVE BETA3 ADRENERGIC RECEPTOR AGONIST USING THE SAME
US6455734B1 (en) *	2000-08-09	2002-09-24	Magnesium Diagnostics, Inc.	Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
EP1078924B1 (en) *	1999-07-23	2004-10-20	Pfizer Products Inc.	Intermediates and a process for producing beta-adrenergic receptor agonists
JPWO2003033468A1 (ja) *	2001-10-17	2005-02-03	株式会社カネカ	（Ｓ）−α−ハロメチルピリジンメタノール誘導体の製造方法
US6864268B2 (en)	2002-02-27	2005-03-08	Pfizer Inc.	β3 adrenergic receptor agonists
WO2003072573A1 (en)	2002-02-27	2003-09-04	Pfizer Products Inc.	Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
MXPA04008298A (es)	2002-02-27	2004-11-26	Pfizer Prod Inc	Procesos e intermedios utiles en la preparacion de agonistas de receptor beta-3 adrenergico.
EP1424079A1 (en) *	2002-11-27	2004-06-02	Boehringer Ingelheim International GmbH	Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
RU2313524C2 (ru)	2003-05-09	2007-12-27	Ф.Хоффманн-Ля Рош Аг	МИТИЛИНДОЛЫ И МЕТИЛПИРРОЛОПИРИДИНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВНОСТЬЮ α-1-АДРЕНЕРГИЧЕСКИХ АГОНИСТОВ
GB2431927B (en)	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en)	2005-11-04	2011-07-12	Amira Pharmaceuticals, Inc.	5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en)	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
BRPI0912267A2 (pt)	2008-05-23	2015-10-13	Amira Pharmaceuticals Inc	sal farmaceuticamente aceitável, composição farmacêutica, artigo de fabricação, métodos para tratar asma, rinite alérgica, doença, lesões gástricas e dor, métodos para prevenir broncoconstrição e rinite alérgica, uso de um sal farmaceuticamente aceitável, e, processo para a preparação de um sal farmaceuticamente aceitável.
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4358455A (en)	1980-12-23	1982-11-09	Merck & Co., Inc.	Aralkylamindethanol heterocyclic compounds
US5019578A (en)	1987-11-27	1991-05-28	Merck & Co., Inc.	β-adrenergic agonists
WO1994029290A1 (en) *	1993-06-14	1994-12-22	Pfizer Inc.	Secondary amines as antidiabetic and antiobesity agents
IL113410A (en) *	1994-04-26	1999-11-30	Merck & Co Inc	Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
EP0828712A1 (en) *	1995-05-10	1998-03-18	Pfizer Inc.	Beta-adrenergic agonists
US5977124A (en) *	1995-05-10	1999-11-02	Pfizer Inc.	β-adrenergic agonists

1997
- 1997-11-03 US US09/297,694 patent/US6291489B1/en not_active Expired - Fee Related
- 1997-11-03 AT AT97945047T patent/ATE319687T1/de not_active IP Right Cessation
- 1997-11-03 EP EP97945047A patent/EP0938476B1/en not_active Expired - Lifetime
- 1997-11-03 CA CA002270386A patent/CA2270386C/en not_active Expired - Fee Related
- 1997-11-03 KR KR1019990704312A patent/KR20000053314A/ko not_active Abandoned
- 1997-11-03 YU YU22099A patent/YU22099A/sh unknown
- 1997-11-03 DE DE69735433T patent/DE69735433D1/de not_active Expired - Lifetime
- 1997-11-03 TR TR1999/01063T patent/TR199901063T2/xx unknown
- 1997-11-03 IL IL12968897A patent/IL129688A0/xx unknown
- 1997-11-03 AU AU46346/97A patent/AU4634697A/en not_active Abandoned
- 1997-11-03 CN CN97199663A patent/CN1237160A/zh active Pending
- 1997-11-03 JP JP52233298A patent/JP3510635B2/ja not_active Expired - Fee Related
- 1997-11-03 WO PCT/IB1997/001367 patent/WO1998021184A1/en not_active Ceased
- 1997-11-03 EA EA199900375A patent/EA199900375A1/ru unknown
- 1997-11-03 BR BR9712951-8A patent/BR9712951A/pt not_active Application Discontinuation
- 1997-11-11 PE PE1997001004A patent/PE10299A1/es not_active Application Discontinuation
- 1997-11-11 MA MA24864A patent/MA24401A1/fr unknown
- 1997-11-11 GT GT199700118A patent/GT199700118A/es unknown
- 1997-11-12 AR ARP970105279A patent/AR010584A1/es not_active Application Discontinuation
- 1997-11-12 UY UY24774A patent/UY24774A1/es unknown
- 1997-11-12 TN TNTNSN97172A patent/TNSN97172A1/fr unknown
- 1997-11-12 MY MYPI97005396A patent/MY132507A/en unknown
- 1997-11-12 PA PA19978441401A patent/PA8441401A1/es unknown
- 1997-11-12 ZA ZA9710186A patent/ZA9710186B/xx unknown
- 1997-11-13 ID IDP973662A patent/ID18898A/id unknown
- 1997-11-13 AP APAP/P/1997/001147A patent/AP805A/en active
- 1997-11-13 HR HR60/030,880A patent/HRP970612A2/hr not_active Application Discontinuation
- 1997-11-13 CO CO97066763A patent/CO4930261A1/es unknown
1999
- 1999-04-16 IS IS5029A patent/IS5029A/is unknown
- 1999-05-07 OA OA9900096A patent/OA11044A/en unknown
- 1999-05-11 BG BG103393A patent/BG103393A/xx unknown
- 1999-05-12 NO NO992296A patent/NO992296D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO992296L (no)	1999-05-12
CA2270386A1 (en)	1998-05-22
BG103393A (en)	2000-07-31
PA8441401A1 (es)	2000-05-24
HRP970612A2 (en)	1998-08-31
WO1998021184A1 (en)	1998-05-22
JP2000504347A (ja)	2000-04-11
YU22099A (sh)	2001-09-28
DE69735433D1 (de)	2006-05-04
JP3510635B2 (ja)	2004-03-29
AP9701147A0 (en)	1998-01-31
CA2270386C (en)	2004-08-03
UY24774A1 (es)	1998-05-05
AU4634697A (en)	1998-06-03
PE10299A1 (es)	1999-02-10
AP805A (en)	2000-01-28
KR20000053314A (ko)	2000-08-25
MY132507A (en)	2007-10-31
OA11044A (en)	2002-02-20
CO4930261A1 (es)	2000-06-27
US6291489B1 (en)	2001-09-18
ZA9710186B (en)	1999-05-12
GT199700118A (es)	1999-05-05
EP0938476B1 (en)	2006-03-08
EP0938476A1 (en)	1999-09-01
EA199900375A1 (ru)	1999-12-29
TR199901063T2 (xx)	1999-08-23
TNSN97172A1 (fr)	2005-03-15
NO992296D0 (no)	1999-05-12
MA24401A1 (fr)	1998-07-01
CN1237160A (zh)	1999-12-01
ID18898A (id)	1998-05-20
IL129688A0 (en)	2000-02-29
ATE319687T1 (de)	2006-03-15
AR010584A1 (es)	2000-06-28
BR9712951A (pt)	1999-12-07

Publication	Publication Date	Title
ID17659A (id)	1998-01-15	Piridin campuran-bisiklik
DE59702034D1 (de)	2000-08-24	2-Aryl-substituierte Pyridine
NO975421D0 (no)	1997-11-25	Fremgangsmåte for fresing i borehull
DE69830295D1 (de)	2005-06-30	Steuerungsverfahren
ATE249437T1 (de)	2003-09-15	Substituierte pyridine als selektive cyclooxygenase inhibitoren
DZ2261A1 (fr)	2002-12-18	Cyclo-alcane pyridines.
ATE393145T1 (de)	2008-05-15	Pyridinderivate
FI980343L (fi)	1999-08-14	Tehonsäätömenetelmä
DE69734266D1 (de)	2005-11-03	Immunoassay-Verfahren
EP0903777A4 (en)	2005-09-14	PATTERN MOLDING
DE69906861D1 (de)	2003-05-22	Steuermethode
IS5029A (is)	1999-04-16	Aðferð fyrir setin pýridín
FI953047L (fi)	1995-12-23	Menetelmä putkien eristämiseksi
DE69841753D1 (de)	2010-08-12	Spurführungregelverfahren
DE69815975D1 (de)	2003-08-07	Steuerungsverfahren
FI961879L (fi)	1996-11-05	Aromatisointimenetelmä
FI973652L (fi)	1999-03-11	Menetelmä makrodiversiteetin toteuttamiseksi
IS5106A (is)	1999-07-02	Ný aðferð
FI980735A7 (fi)	1999-10-01	Viiveenhallintamenetelmä
DE69629942D1 (de)	2003-10-16	Herstellungsverfahren
NO20006531D0 (no)	2000-12-20	Kontrollmetode
DE69816734D1 (de)	2003-09-04	Steuerungsverfahren
FI982091A7 (fi)	2000-03-30	Pääsynhallintamenetelmä
DE69724941D1 (de)	2003-10-23	Aminopyridin-derivate
FI972881A7 (fi)	1998-01-09	Kuidutusmenetelmä